Supernus Pharmaceuticals
SUPN
#5129
Rank
ยฃ1.31 B
Marketcap
ยฃ22.57
Share price
1.78%
Change (1 day)
-34.14%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2026 (TTM): -ยฃ27.36 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ0.86 Billion. In 2025 the company made an earning of -ยฃ32.07 Million a decrease over its 2024 earnings that were of ยฃ60.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ27.36 Million-14.7%
2025 -ยฃ32.07 Million-152.66%
2024 ยฃ60.89 M1446.62%
2023 ยฃ3.93 M-92.36%
2022 ยฃ51.5 M-29.8%
2021 ยฃ73.36 M-49.79%
2020 ยฃ0.14 B12.99%
2019 ยฃ0.12 B7.58%
2018 ยฃ0.12 B54.9%
2017 ยฃ77.6 M84.25%
2016 ยฃ42.12 M202.27%
2015 ยฃ13.93 M-462.04%
2014 -ยฃ3.85 Million-94%
2013 -ยฃ64.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.21 B-51,828.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ5.48 B-20,044.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ26.40 B-96,171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.60 B-31,411.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-ยฃ0.17 Billion 485.87%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
ยฃ1.15 B-4,299.11%๐Ÿ‡บ๐Ÿ‡ธ USA